Atea Pharmaceuticals saw the highest growth of 1.49% in patent filings in April and 0.99% in grants in June in Q2 2024. Compared to Q1 2024, Q2 2024 saw an increase in patent filings by 1.49% and no change in grants. GlobalData’s DataBook provides a comprehensive analysis of Atea Pharmaceuticals‘s patent filings and grants. Buy the databook here.
Smarter leaders trust GlobalData
Atea Pharmaceuticals has been focused on protecting inventions in United States(US) with three publications in Q2 2024
The United States(US) Patent Office dominates the patent filings and grants with nearly 25% filings and 100% grants. The United States(US), European Patent Office(EPO), South Korea(KR), and World Intellectual Property Organization(WIPO) patent Office are among the top ten patent offices where Atea Pharmaceuticals is filings its patents. Among the top granted patent authorities, Atea Pharmaceuticals has 100% of its grants in United States(US).
Gilead Sciences and Johnson & Johnson could be the strongest competitors for Atea Pharmaceuticals
Atea Pharmaceuticals stands in second position with respect to its patent publications among its competitors.
Patents related to climate change and rare diseases lead Atea Pharmaceuticals's portfolio
Atea Pharmaceuticals has the highest number of patents in climate change followed by, rare diseases. For climate change no patents were filed and 50% of patents were granted in Q2 2024.
Hepatitis c related patents lead Atea Pharmaceuticals portfolio followed by dengue fever, and mobiles, hand-helds, pdas, smartphones
Atea Pharmaceuticals has highest number of patents in hepatitis c followed by dengue fever, mobiles, hand-helds, pdas, smartphones, liver cancer, and encephalitis. For hepatitis c, nearly 67% of patents were filed and 8% of patents were granted in Q2 2024.
For comprehensive analysis of Atea Pharmaceuticals's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData patents database covers bibliographic from all 100+ patenting authorities. All patents are tagged to 18+ industries and 300+ sub-sectors based on technology classification, keywords, and associated companies. They are also tagged to various industries themes (100+) and technology domains (1800+) of focus.
Patents database further disambiguates assignee names (13m names) and associate corporate tree hierarchy in current/point in time ownerships (320k entities). GlobalData sources content directly from national patent offices on a weekly basis.
